Procarta awarded £7.4M for microbial treatment
25 September 2019
The company, which has discovered a new type of antimicrobial that kills bacteria by blocking their gene expression, was awarded the funding by CARB-X, a global partnership dedicated to accelerating early antimicrobial R&D.
Further reading: Laboratory News
Author(s): Laboratory News
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!